Evidence map›Paper›PMID 25802472›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Introduction to a thematic issue for WWOX.

Nan-Shan Chang

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Cellular Expression and Subcellular Localization of Wwox Protein During Testicular Development and Spermatogenesis in Rats.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  3. Review
  4. Modeling WWOX Loss of FunctionFrontiers in oncology · 2018
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. HYAL-2-WWOX-SMAD4 Signaling in Cell Death and Anticancer Response.Frontiers in cell and developmental biology · 2016
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Nan-Shan ChangExperimental Biology and Medicine, Institute of Molecular Medicine, National Cheng Kung University, Tainan, 70101 Taiwan; Department of Neuroscience and Physiology, State University of New York Upstate Medical University, Syracuse, NY, 13210 USA; Department of Neurochemistry, NYS Institute of Basic Research for Developmental Disabilities, Staten Island, NY, 10314 USA changns@mail.ncku.edu.tw.
National Cheng Kung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its discovery in 2000, WW domain-containing oxidoreductase (WWOX, FOR or WOX1) has been considered as a tumor suppressor protein. Global research focus has been aimed mainly toward this direction. In this thematic issue, updated information has been collected regarding the structure, function and signaling of WWOX, along with its critical role as a tumor suppressor and participation in metabolism, neurodegeneration, ataxia, epilepsy, neural disorders, neuronal damages, and interactions with oncogenic viruses. WWOX is not a driver of cancer initiation. Chromosomal alterations in the WWOX gene enhance cancer progression. Importantly, a homozygous nonsense mutation of WWOX gene in humans leads to neural pathologies and early death, rather than spontaneous cancer development. These findings suggest new physiological functions of WWOX in metabolism and neural diseases, and these areas require further investigation.

Indexed as

HumansMutationNeoplasmsNervous System DiseasesOxidoreductasesSignal TransductionTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseOxidoreductasesTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, humancancerFORmetabolismneural diseasesWOX1WWOX

Identifiers

PMID25802472
PMCPMC4935221
OpenAlexW2144651215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.